Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, and Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, and Morphological Analysis), and End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, and Others)
Publication Month: Mar 2022 | Report Code: TIPRE00016644 | No. of Pages: 167 | Category: Biotechnology | Status: Published
The frozen tissues samples market is projected to reach US$ 105,045.91 thousand by 2028 from US$ 44,399.07 thousand in 2021. The market is estimated to grow at a CAGR of 13.1% during 2021–2028.
Frozen tissue samples are preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. Frozen tissue samples are also useful in immunohistochemistry as the proteins are still preserved in their native state.
Strategic Insights
The global frozen tissues samples market growth is attributed to the rising application of frozen tissue samples in various research & therapeutic areas and the increasing use of frozen tissue samples due to the rising prevalence of cancer. However, the risk associated with preserving and maintaining frozen tissue samples is hampering the global frozen tissues samples market growth of the market to a certain extent.
Lucrative Regions in Frozen Tissues Samples Market
Get more information on this report :
Increasing Application of Frozen Tissue Samples due to Rising Prevalence of Cancer
According to the data published by Cancer Research UK in 2020, around 0.16 million people in the UK die each year due to cancer. Moreover, as per the Globocan report, in 2020, female breast cancer surpassed lung cancer as the most diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was 2-fold to 3-fold higher in transitioned than transitioning countries. However, female breast and cervical cancer deaths were considerably higher in transitioning than transitioned countries. Such a high prevalence of cancer is driving the need for frozen tissue samples for research and study. The increasing studies using frozen tumor tissue samples establish several diagnosis and treatment scopes for this chronic condition. Hence, the rising incidence of cancer worldwide is fueling the growth of the frozen tissue sample market. Moreover, in Canada, cancer is the leading cause of death among the population, and it is witnessed to be the second-leading cause after heart diseases in the US. According to the American Cancer Society, approximately 1.9 million new cancer cases are diagnosed, and 609,360 deaths in the US are estimated in 2022. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancers remain leading in females. Additionally, lung cancer remains the most common cause of death among the population. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. Therefore, the increasing prevalence of cancer among the population is leading to the growth of the frozen tissue samples market worldwide.
Product-Based Insights
The global frozen tissues samples market, based on product, is segmented into frozen normal tissues samples, frozen tumor tissues samples, and frozen diseased tissue samples. The frozen tissue tumor samples segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the frozen tissues samples market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.
Frozen Tissues Samples Market, by Product – 2021 and 2028
Get more information on this report :
Application-Based Insights
Based on application, the global frozen tissues samples market is segmented into disease diagnosis and treatment, cancer and other diseases research, and morphological analysis. In 2021, the cancer and other diseases research segment accounted for the largest share of the global frozen tissues samples market. However, the diseases diagnosis and treatment segment is expected to grow at the fastest CAGR of 13.8% from 2021 to 2028.
End User-Based Insights
The global frozen tissues samples market, based on end user, is segmented into academic and research institutes, hospitals and clinics, diagnostic centers, and others. In 2021, the academic and research institutes segment held the largest share of the global frozen tissues samples market. However, the hospitals and clinics segment are expected to grow at the fastest CAGR of 13.9% from 2021 to 2028.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the frozen tissues samples market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The global frozen tissues samples market is anticipated to flourish with the development of new innovative products by market players.
Company Profiles
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc
- ZenBio, Inc
- OriGene Technologies, Inc.
- BioChain Institute Inc
- ProteoGenex, Inc.
Frequently Asked Questions
The List of Companies - Frozen Tissues Samples Market
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc.
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc.
- ZenBio, Inc.
- OriGene Technologies, Inc.
- BioChain Institute Inc.
- ProteoGenex, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global frozen tissues samples market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global frozen tissues samples market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
